Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.41 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KMO | O15229 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5734309 | 1.00 | POLB (0.45) | POLBELANEHPGDKCNK3KCNK9 | |
| SCHEMBL1934073 | 0.98 | ELANE (0.42) | POLBELANEHPGDKCNK3KCNK9 | |
| SCHEMBL6858730 | 0.93 | MTNR1A (0.41) | POLBELANEHPGDKCNK3KCNK9 | |
| SCHEMBL4425242 | 0.91 | ELANE (0.41) | ELANEGAAHTT | |
| SCHEMBL11704614 | 0.79 | POLB (0.42) | POLBELANEHPGDKCNK3KCNK9 | |
| SCHEMBL12064486 | 0.79 | HRH3 (0.46) | CHRM2CHRM1LMNA | |
| SCHEMBL18905522 | 0.79 | CHRM2 (0.40) | POLBELANEHPGDRAB9AGAA | |
| SCHEMBL12096955 | 0.78 | POLB (0.41) | POLBELANEHPGDKCNK3KCNK9 | |
| SCHEMBL10861677 | 0.77 | GABBR2 (0.47) | HPGDRAB9AGAAHTTSMN1; SMN2 | |
| SCHEMBL27936204 | 0.77 | EPHX2 (0.45) | RAB9AGAAHTTSMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039195-A | Preparation method of beta-thiocyanate alcohol derivative | 山东省分析测试中心 | 2024-11-29 | — | — | CN | claimed |
| US-7220884-B2 | Hydroaminomethylation of olefins | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2007-05-22 | — | — | US | claimed |
| US-20050215825-A1 | Hydroaminomethylation of olefins | UNION CARBIDE CORPORATION | 2005-09-29 | — | — | US | claimed |
| US-6825378-B2 | TREATING CYCLOHEXYLPHENYL KETONE WITH YLIDE IN ANHYDROUS SOLVENT TO OBTAIN A-CYCLOHEXYLSTYRENE; DIHYDROXYLATION, OXIDATION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-11-30 | — | — | US | claimed |
| US-20040192962-A1 | Process for the synthesis of enantiomerically pure cyclohexylphenyl glycolic acid | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-09-30 | — | — | US | claimed |
| CN-119039195-A | Preparation method of beta-thiocyanate alcohol derivative | 山东省分析测试中心 | 2024-11-29 | — | — | CN | disclosed |
| US-12024590-B2 | Resin composition, prepreg, film with resin, metal foil with resin, metal-clad laminate, and wiring board | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12022611-B2 | Prepreg, metal-clad laminate, and wiring board | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11958951-B2 | Resin composition, prepreg, resin-equipped film, resin-equipped metal foil, metal-cladded layered sheet, and wiring board | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-04-16 | — | — | US | disclosed |
| CN-117720787-A | Flexible metal clad laminate and method of making the same | 科腾聚合物荷兰有限责任公司 | 2024-03-19 | — | — | CN | disclosed |
| US-20240067810-A1 | FLEXIBLE METAL CLAD LAMINATES AND METHODS OF PREPARATION THEREOF | Kraton Corporation (US) | 2024-02-29 | — | — | US | disclosed |
| CN-113061069-B | Oxidative cleavage of compounds containing unsaturated double bonds | 陈建添 | 2024-02-06 | — | — | CN | disclosed |
| US-20040192962-A1 | Process for the synthesis of enantiomerically pure cyclohexylphenyl glycolic acid | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-09-30 | — | — | US | disclosed |
| US-20030187291-A1 | Halogenation with iodine monochloride and iodine monobromide in an aqueous solution, forming a chemical intermediate for the preparation of indinavir, an HIV protease enzyme inhibitor | MERCK SHARP & DOHME CORP. | 2003-10-02 | — | — | US | disclosed |
| EP-1205517-A1 | LOW-HYGROSCOPICITY LOW-BIREFRINGENCE RESIN COMPOSITIONS, MOLDING MATERIAL OBTAINED THEREFROM, SHEET OR FILM, AND OPTICAL PART | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2002-05-15 | — | — | EP | disclosed |
| US-6372911-B1 | REACTING COMPOUND CONTAINING AT LEAST ONE CARBON-CARBON DOUBLE BOND WITH CARBAMATE IN AQUEOUS SOLVENT IN PRESENCE OF BASE, OSMIUM CATALYST, CO-OXIDANT, AND OPTIONALLY ASYMMETRIC LIGAND, TO FORM REACTION MIXTURE CONTAINING BETA-HYDROXY CARBAMATE | MERCK & CO., INC. | 2002-04-16 | — | — | US | disclosed |
| EP-0732337-B1 | Optically active asymmetric diphosphine and process for producing optically active substance in its presence | TAKASAGO PERFUMERY CO LTD (JP) | 2000-09-06 | — | — | EP | disclosed |
| US-5925893-A | POLYESTERURETHANE IONOMER | FUJI XEROX CO., LTD. (JP) | 1999-07-20 | — | — | US | disclosed |
| US-5648548-A | HYDROGENATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1997-07-15 | — | — | US | disclosed |
| EP-0732337-A1 | Optically active asymmetric diphosphine and process for producing optically active substance in its presence | Takasago International Corporation (JP) | 1996-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215825-A1 | Hydroaminomethylation of olefins | HRH2, HRH4, HRH1 | POLB 4584/4885ELANE 4367/4885HPGD 873/4885 |
| US-20030187291-A1 | Halogenation with iodine monochloride and iodine monobromide in an aqueous solution, forming a chemical intermediate for the preparation of indinavir, an HIV protease enzyme inhibitor | IDE, MMP1, CYP3A4 | POLB 379/4885ELANE 689/4885HPGD 1273/4885 |
| US-20040192962-A1 | Process for the synthesis of enantiomerically pure cyclohexylphenyl glycolic acid | GRHPR, PGD, HPD | POLB 2280/4885ELANE 4540/4885HPGD 444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.